注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Lipella Pharmaceuticals Inc是一家臨床階段的生物技術公司。該公司專注於通過對現有仿製藥中的活性劑進行重新配製並針對新應用優化這些重新配製來開發新藥。該公司主要候選產品包括LP-10和 LP-310。LP-10是他克莫司的專有配方,經過優化可局部輸送至膀胱。LP-310是他克莫司的另一種專有配方,經過優化可遞送至口腔粘膜(口腔內壁的組織)和舌頭表面。該公司正在開發LP-310用於治療口腔扁平苔蘚(OLP),這是一種影響口腔粘膜的慢性炎症。該公司開發了一種專有技術,稱為其平台,該技術針對局部疏水藥物輸送到具有內皮表面的體腔進行了優化。其平台包括專為上皮組織使用而優化的專有藥物輸送技術。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Kamal Al-Eryani | - | 2023 | Member of Scientific Advisory Board |
Jonathan Kaufman | 57 | 2005 | Co-Founder, Chairman, CEO, President, Secretary & Treasurer |
Naoki Yoshimura | 67 | 2021 | Independent Director & Member of Advisory Board |
Daniel Cohen | 58 | 2023 | Independent Director |
Alessandro Villa | - | 2023 | Chair of the Scientific Advisory Board |
Michael B. Chancellor | 65 | 2005 | Co-Founder, Chief Medical Officer & Director |
Vidya Sankar | - | 2023 | Member of Scientific Advisory Board |
Ryan Pruchnic | 48 | 2021 | Independent Director |
Leaf Huang | - | - | Member of Advisory Board |
Herve Y. Sroussi | - | 2023 | Member of Scientific Advisory Board |
Roger Roman Dmochowski | - | - | Member of Advisory Board |
Lori A. Birder | 63 | 2023 | Independent Director |
William C. de Groat | - | - | Member of Advisory Board |
Michael Brennan | - | 2023 | Member of Scientific Advisory Board |
Byong Kim | 52 | 2022 | Independent Director |
Jason M. Hafron | - | 2024 | Member of Scientific Advisory Board |
Pradeep Tyagi | - | 2024 | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核